Hepatitis Forums

Hepatitis C Main Forums => Hepatitis C Research News & Studies => Topic started by: Hep Editors on July 12, 2019, 12:13:02 pm

Title: Zepatier Is Highly Effective Among Those With Opioid Use Disorder
Post by: Hep Editors on July 12, 2019, 12:13:02 pm

Merck’s Zepatier (grazoprevir/elbasvir) cures hepatitis C virus (HCV) at high rates among people with opioid use disorder (OUD), according to a pair of real-world studies.

Presenting their findings at the 53rd International Liver Congress in Vienna, researchers analyzed data from the German Hepatitis C Registry (DHC-R) regarding 992 people with genotype 1 of HCV who received 12 or 16 weeks of Zepatier treatment with or without ribavirin.

Read more...
https://www.hepmag.com/article/zepatier-highly-effective-among-opioid-use-disorder